Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-04 2025-01-10 239373
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-30 2025-03-28 249074
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-05-31 217481
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-06 2025-04-04 249766
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214232
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NITRAZEPAM TABLETS BP 10MG TABLET Discontinued 2017-03-13 2018-12-07 1117
APO-NITRAZEPAM TABLETS BP 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40947
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2019-01-04 2019-01-04 71189
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE - CAP 10MG 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE - CAP 25MG 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-OLANZAPINE 2.5MG TABLET Discontinued 2017-03-30 2018-02-05 4738
APO-OLANZAPINE 10.0MG TABLET Discontinued 2018-09-08 2018-12-18 60672
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
APO-PAROXETINE 20MG TABLET Discontinued 2018-09-08 2018-09-15 60684
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-PRAVASTATIN 20MG TABLET Discontinued 2019-01-03 2019-01-03 71014
APO-PROPRANOLOL TAB 20MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1163
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546